N-Acetylneuraminate Lyase (NPL) Antibody (FITC)

Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
N-Acetylneuraminate Lyase (NPL) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx316725

Description

NPL Antibody (FITC) is a Rabbit Polyclonal against NPL conjugated to FITC.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
N-Acetylneuraminate Lyase (NPL)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9BXD5
Gene ID
80896
NCBI Accession
NP_001186979.1, NM_001200050.1, NP_001186980.1, NM_001200051.1, NP_001186985.1, NM_001200056.1, NP_110396.1, NM_030769.2
OMIM
611412
Background
Antibody anti-NPL
Status
RUO

Descripción

Related Products

FNab05820

NPL antibody

Catalyzes the cleavage of N-acetylneuraminic acid(sialic acid) to form pyruvate and N-acetylmannosamine via a Schiff base intermediate. It prevents sialic acids from being recycled and returning to the cell surface. Involved in the N-glycolylneuraminic acid(Neu5Gc) degradation pathway. Although human is not able to catalyze formation of Neu5Gc due to the inactive CMAHP enzyme, Neu5Gc is present in food and must be degraded(By similarity).

Ver Producto
P6579

Recombinant Human NPL

Ver Producto
abx030633

N-Acetylneuraminate Lyase (NPL) Antibody

N-acetylneuraminate pyruvate lyase (EC 4.1.3.3) controls the cellular concentration of sialic acid by catalyzing the conversion of sialic acid into acylmannosamines and pyruvate (Wu et al., 2005 [PubMed 16147865]).

Ver Producto